(Q37226579)

19 August 2017

Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trial (English)

1 reference

19 August 2017

8

Hironobu Sasano

1 reference

19 August 2017

6

Yasuhiro Miki

1 reference

19 August 2017

7

Takashi Suzuki

1 reference

19 August 2017

Matthew J Ellis

1

1 reference

19 August 2017

William R Miller

2

1 reference

19 August 2017

Yu Tao

3

1 reference

19 August 2017

Dean B Evans

4

1 reference

19 August 2017

Hilary A Chaudri Ross

5

1 reference

19 August 2017

language of work or name

English

0 references

publication date

22 October 2008

1 reference

19 August 2017

8

1 reference

Breast Cancer Research and Treatment

inferred from page(s)

published in

1 reference

19 August 2017

116

1 reference

19 August 2017

2

1 reference

19 August 2017

371-378

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-008-0161-8

19 August 2017

0 references

cites work

Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696016

Controversies of aromatase localization in human breast cancer--stromal versus parenchymal cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696016

Aromatase inhibitors and breast cancer.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696016

The validation of new aromatase monoclonal antibodies for immunohistochemistry--a correlation with biochemical activities in 46 cases of breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696016

An integrated view of aromatase and its inhibition

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696016

Endocrine and clinical endpoints of exemestane as neoadjuvant therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696016

Detection of intratumoral aromatase in breast carcinomas. An immunohistochemical study with clinicopathologic correlation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696016

Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696016

Prognostic value of breast cancer aromatase

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696016

Letrozole inhibits tumor proliferation more effectively than tamoxifen independent of HER1/2 expression status

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696016

Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696016

Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696016

Oestradiol synthesis by a human breast carcinoma

3 September 2018

1 reference

12 December 2020

Significance of aromatase activity in human breast cancer

1 reference

12 December 2020

Aromatisation of androstenedione by human breast cancer tissue: correlation with hormone receptor activity and possible biologic significance

1 reference

12 December 2020

Relationship between tumour aromatase activity, tumour characteristics and response to therapy

1 reference

12 December 2020

Concentrations of oestrone and 4-hydroxyandrostenedione in malignant and normal breast tissues

1 reference

12 December 2020

Aromatase activity in breast tissue

1 reference

12 December 2020

The role of aromatase in breast tumors

1 reference

12 December 2020

10.1007/S10549-008-0161-8

Identifiers

DOI

1 reference

19 August 2017

1 reference

19 August 2017

1 reference